A life-saving device that detects silent heart attacks | Akash Manoj

Episode Summary

Executive Summary: Akash Manoj describes how losing his grandfather to a silent heart attack inspired him to develop a low-cost, wearable device that continuously monitors cardiac biomarkers to detect heart attacks early, especially in at-risk patients who may not feel symptoms. He argues medicine should shift from reactive treatment to proactive prevention.

Main Topics: Personal motivation and origin story (Priority: 5/5): The talk begins with Manoj’s grandfather’s death from a silent heart attack, which became the emotional catalyst for his research and invention. Silent heart attacks and diagnostic challenges (Priority: 5/5): He explains that silent heart attacks are common, dangerous, and difficult to detect because symptoms may be absent, especially in patients with diabetes-related nerve damage. Limitations of current heart attack diagnosis (Priority: 4/5): Manoj criticizes existing gold-standard tests and treatments as time-consuming, expensive, and often too late to prevent damage once symptoms appear. Biomarkers as early warning signals (Priority: 5/5): He emphasizes that cardiac biomarkers in the bloodstream can serve as SOS signals from the heart before severe injury occurs. Wearable non-invasive detection device (Priority: 5/5): He presents a silicon patch worn on the wrist or near the chest that tracks HFABP biomarker levels continuously and alerts users when levels become critical. Clinical validation and accessibility (Priority: 4/5): He reports promising validation results and proposes two versions of the device: a digital model and a simpler vibrating version for rural users. Shift from sick care to preventive healthcare (Priority: 5/5): The talk concludes with a call to rethink medicine toward proactive, technology-enabled prevention rather than waiting for heart attacks to happen.

Key Arguments: Silent heart attacks are especially dangerous because patients often do not recognize symptoms and therefore delay care. People with diabetes are at higher risk because nerve damage can mask pain signals that would normally warn of a heart attack. Current diagnostic methods are too slow, costly, and invasive for continuous monitoring of at-risk patients. Cardiac biomarkers can provide earlier detection than symptom-based diagnosis if monitored in real time. A wearable, non-invasive patch could continuously track biomarker levels and warn patients before a cardiac event becomes fatal. A low-cost, portable solution could improve access in both urban and rural settings. Healthcare should prioritize prevention and early warning systems rather than relying mainly on post-event treatment.

Data Points: Annual heart attack deaths: nearly 8 million - Estimated number of people who die from heart attacks every year, cited to show the scale of the problem. Silent heart attacks share of all heart attacks: nearly 45% - Manoj states that silent heart attacks make up a large portion of all heart attacks. Research timeline: 3 years - He says he spent three years researching and developing the solution. Clinical validation accuracy and sensitivity: close to 96% - Reported result from tests on at-risk patients under observation.

Pivotal Quotes: "I decided to go out on a war against this deadly killer and see what could be done." — Akash Manoj: Explaining the personal motivation sparked by his grandfather’s death. "It is more of sick care than preventative self-care and technology." — Akash Manoj: His critique of the current healthcare model. "A change must be brought out not 10 years from now, not 5 years from now, but today." — Akash Manoj: His closing call for immediate adoption of proactive healthcare technologies.

Implications: If adopted, wearable biomarker monitoring could help detect heart attacks earlier, reduce invasive testing, and save lives—especially for high-risk and underserved patients. It also points to a broader shift toward preventive, continuous healthcare.